Next Article in Journal
Early Salvage Chemo-Immunotherapy with Irinotecan, Temozolomide and Naxitamab Plus GM-CSF (HITS) for Patients with Primary Refractory High-Risk Neuroblastoma Provide the Best Chance for Long-Term Outcomes
Previous Article in Journal
A Novel Role of Connective Tissue Growth Factor in the Regulation of the Epithelial Phenotype
 
 
Review

Article Versions Notes

Cancers 2023, 15(19), 4836; https://doi.org/10.3390/cancers15194836
Action Date Notes Link
article xml file uploaded 2 October 2023 16:29 CEST Original file -
article xml uploaded. 2 October 2023 16:29 CEST Update -
article pdf uploaded. 2 October 2023 16:29 CEST Version of Record -
article html file updated 2 October 2023 16:31 CEST Original file -
article xml file uploaded 2 October 2023 16:45 CEST Update -
article xml uploaded. 2 October 2023 16:45 CEST Update https://www.mdpi.com/2072-6694/15/19/4836/xml
article pdf uploaded. 2 October 2023 16:45 CEST Updated version of record https://www.mdpi.com/2072-6694/15/19/4836/pdf
article html file updated 2 October 2023 16:46 CEST Update https://www.mdpi.com/2072-6694/15/19/4836/html
Back to TopTop